Amicus Therapeutics Inc. buy StockNews.com
Start price
26.10.25
/
50%
€7.45
Target price
26.10.26
-
Performance (%)
62.42%
Price
12.01.26
€12.10
Summary
This prediction is currently active. The BUY prediction by StockNews_com for Amicus Therapeutics Inc. has seen massive gains of 62.42%. This prediction currently runs until 26.10.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | 1.667% | 1.667% |
| iShares Core DAX® | 2.331% | 5.140% |
| iShares Nasdaq 100 | 2.077% | 2.956% |
| iShares Nikkei 225® | 2.759% | 7.214% |
| iShares S&P 500 | 1.613% | 2.893% |
Comments by StockNews_com for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics (NASDAQ:FOLD) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for FOLD provided by MarketBeat
Stopped prediction by StockNews_com for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€9.20
16.11.24
16.11.24
-
16.11.25
16.11.25
-11.96%
17.11.25
17.11.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.70
11.03.23
11.03.23
-
11.03.24
11.03.24
2.80%
12.03.24
12.03.24